Clinical Trials Directory

Trials / Completed

CompletedNCT02733913

Clinical Impact of Autonomic Modulation After Pulmonary Vein Isolation

Clinical Impact of Autonomic Modulation After Pulmonary Vein Isolation in Patients With Paroxysmal Atrial Fibrillation

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Klinik für Kardiologie, Pneumologie und Angiologie · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Pulmonary vein isolation (PVI) has become a standard therapy for atrial fibrillation (AF), however, there is still considerable AF recurrence after PVI. Except for PV-left atrium (LA) reconnection, the cause of recurrence has been not yet fully clarified. The alternation of autonomic tone plays an important role in initiation of paroxysmal AF. It was reported that there are multiple gangliated plexus (GP) around pulmonary veins, therefore the modulation targeting those GPs, resulting in modulations of cardiac autonomic tone, have been conducted. Some study showed the efficacy of GP ablation for AF patients. According to the previous reports, heart rate (HR) increased, and heart rate variability (HRV) reduced after PVI. These are considered to be due to "autonomic denervation" caused by catheter ablation of GP. For the best of investigators knowledge, there have been no data on heart rate turbulence (HRT) of baroreflex sensitivity (BRS) concerning PVI.

Conditions

Timeline

Start date
2014-08-01
Primary completion
2017-03-31
Completion
2017-03-31
First posted
2016-04-12
Last updated
2017-11-14

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02733913. Inclusion in this directory is not an endorsement.